Welcome to our dedicated page for Arqit Quantum SEC filings (Ticker: ARQQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arqit Quantum Inc. filings document foreign private issuer disclosures for a quantum-safe encryption software company listed on Nasdaq under ARQQ and ARQQW. Recent Form 6-K reports furnish preliminary financial results, revenue-recognition context tied to customer contracts, board and audit committee changes, executive-transition matters, and litigation contingency updates.
The filing record also references registration statements on Form S-8 and Form F-3, linking current reports to equity compensation and securities-registration disclosures. These documents frame Arqit’s public-company reporting around governance, capital structure, operating results, litigation contingencies and material events associated with its cybersecurity business.
Arqit Quantum Inc. Chief Financial Officer Nicholas Pointon reported a mix of share acquisitions and sales. On April 1, 2026, he exercised Restricted Stock Units (RSUs) that convert into Arqit ordinary shares on a one-for-one basis, acquiring additional ordinary shares at a conversion price of $0.00 per share. On April 2, 2026, he completed an open-market sale of 1,709 ordinary shares at $13.32 per share. After these transactions, he held 13,607 ordinary shares directly. Footnotes state that various RSU grants vest quarterly in equal installments on specified dates through 2028.
Arqit Quantum Inc. director Ritchie Garth reported a mix of share sales and equity awards activity. On April 2, 2026, he completed an open-market sale of 512 Ordinary Shares at $13.2463 per share, leaving 28,800 Ordinary Shares held directly afterward.
On April 1, 2026, multiple Restricted Stock Units (RSUs) were exercised at a $0.00 conversion price, delivering a total of 1,051 Ordinary Shares. The RSUs convert into Ordinary Shares on a one-for-one basis and vest in quarterly installments through 2028 under several schedules described in the footnotes.
Arqit Quantum Inc. Chief Operating Officer Wilder Ben Simon reported a mix of equity awards vesting and a small share sale. On April 1, 2026, he exercised 1,333 Restricted Stock Units (RSUs), converting them into the same number of ordinary shares at a $0.00 exercise price under compensation arrangements where RSUs convert one-for-one into ARQQ ordinary shares.
On April 2, 2026, he completed an open-market sale of 683 ordinary shares at an average price of $13.3112 per share. After these transactions, he directly holds 3,018.47 ordinary shares. Footnotes explain that RSUs vest quarterly in equal installments on specified dates from 2026 through 2028, spreading the delivery of additional shares over multiple future vesting dates.
Arqit Quantum Inc. General Counsel Patrick Willcocks reported a mix of equity exercises and a sale of company stock. On April 1, 2026, he exercised Restricted Stock Units (RSUs) that converted one-for-one into 3,563 ordinary shares at a conversion price of $0.00 per share, consistent with the RSU footnotes. On April 2, 2026, he executed an open-market sale of 1,790 ordinary shares at $13.3233 per share. After these transactions, he directly held 11,916 ordinary shares, so he retained a meaningful equity position in the company.
Arqit Quantum Inc. Chief Executive Officer Andrew Leaver exercised restricted stock units and received additional ordinary shares. On April 1, 2026, he converted 15,625 RSUs into 15,625 ordinary shares at an exercise price of $0.00 per share.
Following the transaction, Leaver directly holds 53,346 ordinary shares and 218,750 restricted stock units. The RSUs convert into ordinary shares on a one-for-one basis and vest quarterly on April 1, July 1 and October 1 of 2026, and on January 1, April 1, July 1 and October 1 of 2027, 2028 and 2029.
Filer submitted a Rule 144 notice reporting restricted common stock vesting and recent sales. The filing lists 1,709 shares tied to a Restricted Stock Vesting event dated 04/01/2026. It also itemizes three past sales by Nicholas Pointon dated 01/02/2026, 02/20/2026, and 02/25/2026 with corresponding amounts.
ARQQ submitted a Rule 144 notice reporting 1,790 shares of Common Stock to be sold following restricted stock vesting dated 04/01/2026. The filing lists Fidelity Brokerage Services LLC as the broker. The filing also lists prior open-market sales by Patrick Willcocks of 1,913; 3,000; and 520 shares on 01/02/2026, 01/06/2026, and 03/04/2026, respectively. Shares outstanding are shown as 15,291,767 as of 04/02/2026.
ARQQ submitted a Rule 144 notice reporting the sale/vesting of common stock. The filing lists 683 shares tied to a restricted stock vesting event dated 04/01/2026. It also reports 717 shares sold in the past three months with a trade date of 01/02/2026.
ARQQ submitted a Form 144 notice relating to proposed sales of Common stock. The filing lists Restricted Stock Vesting dated 04/01/2026 and contains a filer entry for Fidelity Brokerage Services LLC with an action date of 04/02/2026. The filing also records a sale-related entry for Paul Feenan dated 01/02/2026.